Magsari, Rowena .

HRN: 21-95-52  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2022
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
10/13/2022
10/16/2022
PO
5ml
BID
Ascariasis; Trichiuriasis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: